- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02965469
Psychosocial Stress and Aging in HIV
14. april 2022 opdateret af: Wake Forest University Health Sciences
The Syndemic of Stress and Aging in an HIV-infected Population
This study will begin to assess the association between perceived stress and enhanced aging in persons living with HIV (PLWH).
The investigators suspect this relationship may be mediated by increased aging within the immune system and subsequent low-level inflammation that commonly leads to multiple illnesses and frailty as one ages.
The findings from this study will identify potential diagnostic and therapeutic targets to improve the health of aging PLWH which could also apply to HIV-uninfected populations.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
While life expectancy has increased markedly for people living with HIV (PLWH), gains in expected years of life have come at a cost - earlier onset and greater frequency of age-associated comorbid conditions, such as osteoporosis, metabolic syndrome, and cardiovascular disease.
Accumulated multi-morbidity is the likely cause of much higher than age-expected rates of frailty in PLWH.
Perceived stress is prevalent in PLWH and, when present, associated with worse clinical outcomes, including poor engagement in HIV care, rapid progression to AIDS, and higher AIDS-related mortality.
Stress is a well-documented risk factor for many illnesses that demonstrate early onset in PLWH, and perceived stress has been hypothesized to be a cause of aging itself.
Nonetheless, the role of perceived stress in early-onset aging and age-related illness in PLWH is essentially unexplored.
Investigating the interrelatedness of aging, perceived stress, and HIV may elucidate mechanism(s) that underlie a phenotype of premature aging and functional decline in HIV patients with implications for understanding fundamental mechanisms of stress and aging in HIV uninfected populations.
The proposed randomized controlled study will estimate correlations between perceived stress and both aging and HIV-specific outcomes and will measure feasibility of a cell phone-delivered stress reduction intervention.
Participants will complete structured interviews to measure cumulative life stress, perceived stress, intimate partner violence exposure (as a traumatic stressor), functional status, frailty, and potential covariates across the age spectrum in PLWH.
Stress measures will be correlated with biomarkers known to be associated with functional decline in aging, HIV-uninfected populations.
The findings from this exploratory R03, led by a New Investigator, will measure feasibility of mobile technology for stress reduction interventions and estimate correlations between perceived stress and markers of aging and HIV disease.
The results will be used to determine sample sizes necessary to perform definitive studies to assess the link between perceived stress and a phenotype of premature aging, as well as interventional studies of stress modification to mitigate the onset of early multi-morbidity and functional decline.
These findings can be applicable to both HIV-infected and HIV-uninfected populations.
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
42
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
North Carolina
-
Winston-Salem, North Carolina, Forenede Stater, 27157
- Wake Forest University Health Sciences
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
21 år og ældre (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- HIV positive serostatus
- Wake Forest ID clinic patient for at least 12 months
- prescribed ART for at least 6 months
- English fluency (cell phone app and some interview tools are only available in English)
- consistent access to a smartphone
Exclusion Criteria:
- ART-naive
- unable to perform functional measures
- recent (within 30 days) acute illness requiring medical therapy or hospitalization
- immunosuppressive agents (e.g. > 20 mg/d prednisone or equivalent, chemotherapy, biologic immune-modulating agents) in the last 6 months
- cancer requiring treatment within 3 years (except for non-melanoma skin cancer)
- use of non-steroidal anti-inflammatory drugs more frequently than once per week within the last 30 days.
Criteria iii-vi are necessary because of their effects on biomarkers of aging
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Andet
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Ingen indgriben: Usual care
Participants randomized to this arm will have no change to their usual care
|
|
Eksperimentel: Cell phone app
Participants randomized to this arm will use a stress reduction cell phone app called "Breathe2Relax" to assess feasibility and acceptability
|
The app teaches diaphragmatic breathing and has audiovisual coaching
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Correlation of perceived stress with HIV virologic suppression
Tidsramme: 12 weeks
|
Measure perceived stress using the Perceived Stress Scale (PSS) and calculate the correlation with HIV viral load
|
12 weeks
|
Correlation of perceived stress with immune senescence
Tidsramme: 12 weeks
|
Measure perceived stress using the Perceived Stress Scale (PSS) and calculate the correlation with biomarkers of immune senescence, including IL-6, soluble CD-14, telomere length, and DNA methylation
|
12 weeks
|
Correlation of perceived stress with inflammation
Tidsramme: 12 weeks
|
Measure perceived stress using the Perceived Stress Scale (PSS) and calculate the correlation with biomarkers of inflammation (C-reactive protein, salivary cortisol)
|
12 weeks
|
Correlation of perceived stress with frailty phenotype
Tidsramme: 12 weeks
|
Measure perceived stress using the Perceived Stress Scale (PSS) and calculate the correlation with each participant's Fried Frailty Index score (comprised of 5 items, including weight loss, exhaustion, 4 meter walk time, physical activity, and grip strength).
|
12 weeks
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Feasibility of a stress-reduction cell phone app
Tidsramme: 12 weeks
|
This outcome will measure the accrual, adherence and retention of using a stress-reduction cell phone application in people aging with HIV through the randomized pilot study.
|
12 weeks
|
The effect of a cell phone app on stress-reduction
Tidsramme: 12 weeks
|
The study will collect preliminary data on the efficacy of a cell phone-based stress reduction intervention versus usual care for improving markers of inflammation and aging, as well as HIV-specific outcomes.
|
12 weeks
|
Acceptability of a stress-reduction cell phone app
Tidsramme: 12 weeks
|
An exit survey will measure the acceptability of using a stress-reduction cell phone application in people aging with HIV.
|
12 weeks
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Katherine R Schafer, MD, Associate Professor
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. maj 2016
Primær færdiggørelse (Faktiske)
14. november 2017
Studieafslutning (Faktiske)
14. november 2017
Datoer for studieregistrering
Først indsendt
4. november 2016
Først indsendt, der opfyldte QC-kriterier
11. november 2016
Først opslået (Skøn)
16. november 2016
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
15. april 2022
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
14. april 2022
Sidst verificeret
1. juli 2018
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- IRB00033537
- 1R03AG048033-01A1 (U.S. NIH-bevilling/kontrakt)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .